Abstract:Abstract. Significant progress has been made over the past 25 years in the development of in vitro-engineered substitutes that mimic human skin, either to be used as grafts for the replacement of lost skin, or for the establishment of in vitro human skin models. In this sense, laboratory-grown skin substitutes containing dermal and epidermal components offer a promising approach to skin engineering. In particular, a human plasma-based bilayered skin generated by our group, has been applied successfully to trea… Show more
“…It was demonstrated that cell viability in the skin-like construct was above 90% in 1 week [74]. Moreover, Cubo et al created a human plasma-based bilayer skin-like tissue containing plasma-derived fibrin, fibroblasts and keratinocytes, which had successfully used for the treatment of burnt, traumatic and surgical wounds in many patients [75]. The results revealed that the printed skin-like tissue, both in vitro culture and in transplantation to immunedeficient mice, showed similar characteristics with human skin [75].…”
Three-dimensional (3D) bioprinting is a computer-assisted technology which precisely controls spatial position of biomaterials, growth factors and living cells, offering unprecedented possibility to bridge the gap between structurally mimic tissue constructs and functional tissues or organoids. We briefly focus on diverse bioinks used in the recent progresses of biofabrication and 3D bioprinting of various tissue architectures including blood vessel, bone, cartilage, skin, heart, liver and nerve systems. This paper provides readers a guideline with the conjunction between bioinks and the targeted tissue or organ types in structuration and final functionalization of these tissue analogues. The challenges and perspectives in 3D bioprinting field are also illustrated.
“…It was demonstrated that cell viability in the skin-like construct was above 90% in 1 week [74]. Moreover, Cubo et al created a human plasma-based bilayer skin-like tissue containing plasma-derived fibrin, fibroblasts and keratinocytes, which had successfully used for the treatment of burnt, traumatic and surgical wounds in many patients [75]. The results revealed that the printed skin-like tissue, both in vitro culture and in transplantation to immunedeficient mice, showed similar characteristics with human skin [75].…”
Three-dimensional (3D) bioprinting is a computer-assisted technology which precisely controls spatial position of biomaterials, growth factors and living cells, offering unprecedented possibility to bridge the gap between structurally mimic tissue constructs and functional tissues or organoids. We briefly focus on diverse bioinks used in the recent progresses of biofabrication and 3D bioprinting of various tissue architectures including blood vessel, bone, cartilage, skin, heart, liver and nerve systems. This paper provides readers a guideline with the conjunction between bioinks and the targeted tissue or organ types in structuration and final functionalization of these tissue analogues. The challenges and perspectives in 3D bioprinting field are also illustrated.
“…Nieves Cubo et al used primary human FBs and human KCs as well as human plasma to print a human bi‐layered skin. According to the histological and immunohistochemical in vivo and in vitro analyses, they demonstrated that the printed skin was very similar to normal human skin and successfully used the in clinical . Byoung Soo Kim et al used FBs and KCs to fabricate a human skin model with a functional transwell system by using extrusion and inkjet modules synchronously .…”
Section: Cell Selectionmentioning
confidence: 99%
“…It is more suitable for the bioprinting of 3D scaffolds in most solid organs, blood vessels, and hard tissues. The potential applied advantages of a microextrusion bioprinter make it a promising printer in the construction of bioprinting skin substitutes . Its main drawback is the low resolution (below 50 μm) and the shear stress that may affect cell viability .…”
Section: D Bioprintermentioning
confidence: 99%
“…In addition, novel materials for ideal bioink must also be considered. Currently, gelatin hydrogels are widely used as bioink for their high biocompatibility . However, the printed construct's disadvantages of severe contraction, fast degradation, and limited lifespan cannot be ignored .…”
Essential cellular functions that are present in tissues are missed by two‐dimensional (2D) cell monolayer culture. It certainly limits their potential to predict the cellular responses of real organisms. Engineering approaches offer solutions to overcome current limitations. For example, establishing a three‐dimensional (3D)‐based matrix is motivated by the need to mimic the functions of living tissues, which will have a strong impact on regenerative medicine. However, as a novel approach, it requires the development of new standard protocols to increase the efficiency of clinical translation. In this review, we summarised the various aspects of requirements related to well‐suited 3D bioprinting techniques for skin regeneration and discussed how to overcome current bottlenecks and propel these therapies into the clinic.
“…These results demonstrate that 3D bioprinting is a suitable technology to generate bioengineered skin for therapeutical and industrial applications in an automatized manner. [106] Koch et al selected different skin cells (fibroblasts, keratinocytes) and hMSC based on their high potential in regeneration of human skin and possible applications in stem cell therapy for their laser printing experiments. [107] This group generated a viable skin tissue free of any DNA damage.…”
“Engineered human organs” hold promises for predicting the effectiveness and accuracy of drug responses while reducing cost, time, and failure rates in clinical trials. Multiorgan human models utilize many aspects of currently available technologies including self‐organized spherical 3D human organoids, microfabricated 3D human organ chips, and 3D bioprinted human organ constructs to mimic key structural and functional properties of human organs. They enable precise control of multicellular activities, extracellular matrix (ECM) compositions, spatial distributions of cells, architectural organizations of ECM, and environmental cues. Thus, engineered human organs can provide the microstructures and biological functions of target organs and advantageously substitute multiscaled drug‐testing platforms including the current in vitro molecular assays, cell platforms, and in vivo models. This review provides an overview of advanced innovative designs based on the three main technologies used for organ construction leading to single and multiorgan systems useable for drug development. Current technological challenges and future perspectives are also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.